FDA-approved & Passed Phase I Drug Library (C007B-571825)

• A unique collection of 3010 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development• Safety confirmed by clinical phase 1• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc• Structurally diverse, medicinally active, and cell permeable.• Rich documentation with structure, IC50, and customer reviews• NMR and HPLC validated to ensure the highest purityProduct DetailsFormulation 2678 compounds pre-dissolved in 10mM DMSO，244 compounds pre-dissolved in 10mM H2O,72 compounds pre-dissolved in 2mM DMSO，16 compounds pre-dissolved in 2mM H2O Container 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D BarcodeStability 12 months -20°C in DMSO24 months -80°C in DMSOFDA-approved & Passed Phase I Drug Library Composition